AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $106,000 | -70.7% | 15,531 | -65.3% | 0.00% | -100.0% |
| Q4 2021 | $362,000 | -10.6% | 44,758 | +8.4% | 0.00% | -50.0% |
| Q3 2021 | $405,000 | +45.7% | 41,286 | -0.1% | 0.00% | +100.0% |
| Q2 2021 | $278,000 | -33.5% | 41,336 | -10.7% | 0.00% | -50.0% |
| Q1 2021 | $418,000 | +164.6% | 46,286 | +95.7% | 0.00% | +100.0% |
| Q4 2020 | $158,000 | -56.8% | 23,655 | -83.3% | 0.00% | -75.0% |
| Q4 2018 | $366,000 | -63.4% | 141,856 | -37.7% | 0.00% | -55.6% |
| Q3 2018 | $999,000 | -17.8% | 227,573 | +14.8% | 0.01% | -25.0% |
| Q2 2018 | $1,215,000 | -14.6% | 198,223 | +1.5% | 0.01% | -14.3% |
| Q1 2018 | $1,423,000 | -8.7% | 195,223 | +2.8% | 0.01% | -12.5% |
| Q4 2017 | $1,558,000 | -25.8% | 189,973 | -5.0% | 0.02% | -33.3% |
| Q3 2017 | $2,100,000 | – | 199,976 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |